Literature DB >> 11552888

Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma.

A Knuuttila1, L Kivisaari, A Kivisaari, M Palomäki, P Tervahartiala, K Mattson.   

Abstract

PURPOSE: To evaluate MR imaging and CT in differentiating malignant pleural mesothelioma from other malignancies or benign pleural disease.
MATERIAL AND METHODS: Thirty-four patients (18 pleural mesotheliomas, 9 other malignancies, 7 benign pleural diseases) were examined using enhanced CT and MR. Two radiologists reviewed the CT and two others the MR images. Comparisons were made between the diagnostic groups and the imaging methods.
RESULTS: The abnormalities commonly found in malignant disease, but significantly less frequently in benign pleural disease, were focal thickening and enhancement of interlobar fissures. In mesothelioma, enhancement of interlobar fissures, tumour invasion of the diaphragm, mediastinal soft tissue or chest wall, were significantly more often observed than in other malignancies and MR was the most sensitive method. In other malignancies, invasion of bony structures was a more common finding and was also better shown by MR. The contrast-enhanced T1 fat-suppressed (CET1fs) sequence detected these features better than other MR sequences.
CONCLUSION: MR, especially the CET1fs sequence in three planes, gave more information than enhanced CT. Focal thickening and enhancement of interlobar fissures were early abnormalities indicating malignant pleural disease. MR could be clinically useful for differentiating mesothelioma from other pleural diseases.

Entities:  

Mesh:

Year:  2001        PMID: 11552888     DOI: 10.1080/028418501127347070

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.701


  8 in total

Review 1.  [Magnetic resonance imaging in the evaluation of pneumonia].

Authors:  R Eibel; P Herzog; O Dietrich; C Rieger; H Ostermann; M Reiser; S Schoenberg
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

2.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

3.  Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT.

Authors:  Christian Plathow; Michael Klopp; Christian Thieke; Felix Herth; Andreas Thomas; Astrid Schmaehl; Ivan Zuna; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

Review 4.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

5.  3T MRI in evaluation of asbestos-related thoracic diseases - preliminary results.

Authors:  Janez Podobnik; Igor Kocijancic; Viljem Kovac; Igor Sersa
Journal:  Radiol Oncol       Date:  2010-05-24       Impact factor: 2.991

6.  Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.

Authors:  Selina Tsim; Catherine A Humphreys; Gordon W Cowell; David B Stobo; Colin Noble; Rosemary Woodward; Caroline A Kelly; Laura Alexander; John E Foster; Craig Dick; Kevin G Blyth
Journal:  Lung Cancer       Date:  2018-02-03       Impact factor: 5.705

Review 7.  Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.

Authors:  Luciano Cardinale; Francesco Ardissone; Dario Gned; Nicola Sverzellati; Edoardo Piacibello; Andrea Veltri
Journal:  Acta Biomed       Date:  2017-08-23

Review 8.  The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis.

Authors:  Federica Volpi; Caterina A D'Amore; Leonardo Colligiani; Alessio Milazzo; Silvia Cavaliere; Annalisa De Liperi; Emanuele Neri; Chiara Romei
Journal:  Diagnostics (Basel)       Date:  2022-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.